Literature DB >> 12885733

Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.

Lynne Warner Stevenson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12885733     DOI： 10.1161/01.CIR.0000078349.43742.8A

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  24 in total

1.  Left Ventricular Assist Devices as Destination Therapy for End-stage Heart Failure.

Authors:  Lynne Warner Stevenson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-12

2.  Lipid-mediated folding/unfolding of phospholamban as a regulatory mechanism for the sarcoplasmic reticulum Ca2+-ATPase.

Authors:  Martin Gustavsson; Nathaniel J Traaseth; Christine B Karim; Elizabeth L Lockamy; David D Thomas; Gianluigi Veglia
Journal:  J Mol Biol       Date:  2011-03-17       Impact factor: 5.469

Review 3.  End-of-life options for patients with advanced heart failure.

Authors:  Judith Z Goldfinger; Eric D Adler
Journal:  Curr Heart Fail Rep       Date:  2010-09

4.  Role of cardiac resynchronization in end-stage heart failure patients requiring inotrope therapy.

Authors:  Sanjoy Bhattacharya; Kaleab Abebe; Marc Simon; Samir Saba; Evan Adelstein
Journal:  J Card Fail       Date:  2010-12       Impact factor: 5.712

Review 5.  Cardiac autonomic nerve stimulation in the treatment of heart failure.

Authors:  Mariko Kobayashi; Alex Massiello; Jamshid H Karimov; David R Van Wagoner; Kiyotaka Fukamachi
Journal:  Ann Thorac Surg       Date:  2013-06-05       Impact factor: 4.330

Review 6.  Cardiac Myosin Activators in Systolic Heart Failure: More Friend than Foe?

Authors:  Danyaal S Moin; Julia Sackheim; Carine E Hamo; Javed Butler
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

7.  Inotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiology.

Authors:  Andreas P Kalogeropoulos; Catherine N Marti; Vasiliki V Georgiopoulou; Javed Butler
Journal:  J Card Fail       Date:  2014-05-28       Impact factor: 5.712

8.  Evaluation of the anti-ischemic effects of D-ribose during dobutamine stress echocardiography: a pilot study.

Authors:  Stephen G Sawada; Stephen Lewis; Roxanne Kovacs; Samer Khouri; Irmina Gradus-Pizlo; John A St Cyr; Harvey Feigenbaum
Journal:  Cardiovasc Ultrasound       Date:  2009-02-07       Impact factor: 2.062

Review 9.  Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.

Authors:  John R Teerlink; Marco Metra; Valerio Zacà; Hani N Sabbah; Gadi Cotter; Mihai Gheorghiade; Livio Dei Cas
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

Review 10.  Management of end-stage heart failure: a perspective on the Arab Gulf states.

Authors:  Waleed Al Habeeb; Garrick C Stewart; Gilbert H Mudge
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.